• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雾化吸入肝素联合 N-乙酰半胱氨酸和沙丁胺醇可缩短吸入性损伤患者的机械通气时间。

Nebulized Heparin With N-Acetylcysteine and Albuterol Reduces Duration of Mechanical Ventilation in Patients With Inhalation Injury.

作者信息

McGinn Kaitlin A, Weigartz Katie, Lintner Alicia, Scalese Michael J, Kahn Steven A

机构信息

1 Department of Pharmacy Practice, Auburn University Harrison School of Pharmacy, Auburn, AL, USA.

2 Department of Surgery, University of South Alabama Medical Center, Mobile, AL, USA.

出版信息

J Pharm Pract. 2019 Apr;32(2):163-166. doi: 10.1177/0897190017747143. Epub 2017 Dec 12.

DOI:10.1177/0897190017747143
PMID:29233052
Abstract

OBJECTIVE

Nebulized heparin has been proposed to improve pulmonary function in patients with inhalation injuries. The purpose of this study was to evaluate the impact of nebulized heparin with N-acetylcysteine (NAC) and albuterol on the duration of mechanical ventilation in burn patients.

METHODS

This is a retrospective study evaluating mechanically ventilated adult patients admitted to a regional burn center with inhalation injury. Outcomes were compared between patients who were prescribed a combination of nebulized heparin with NAC and albuterol versus similar patients who did not.

RESULTS

A total of 48 patients met inclusion criteria (heparin n = 22; nonheparin n = 26). Patients in the nonheparin group had higher percentage of total body surface area (TBSA) burned (29.00 [5.75-51.88] vs 5.25 [0.50-13.25] %TBSA; P = .009), longer duration of mechanical ventilation (6.50 [2.75-17.00] vs 3.00 [1.00-8.25] days; P = .022), and longer intensive care unit length of stay (LOS) (3.00 [3.00-28.75] vs 5.50 days [2.00-11.25]; P = .033). Upon regression, use of heparin was the only variable associated with reducing the duration of mechanical ventilation ( P = .039).

CONCLUSION

Nebulized heparin in combination with NAC and albuterol was associated with a significant reduction in the duration of mechanical ventilation.

摘要

目的

雾化吸入肝素已被提议用于改善吸入性损伤患者的肺功能。本研究的目的是评估雾化吸入肝素联合N - 乙酰半胱氨酸(NAC)和沙丁胺醇对烧伤患者机械通气时间的影响。

方法

这是一项回顾性研究,评估入住某地区烧伤中心的成年机械通气吸入性损伤患者。将接受雾化吸入肝素联合NAC和沙丁胺醇治疗的患者与未接受该治疗的类似患者的结局进行比较。

结果

共有48例患者符合纳入标准(肝素组n = 22;非肝素组n = 26)。非肝素组患者的烧伤总面积(TBSA)百分比更高(29.00 [5.75 - 51.88] vs 5.25 [0.50 - 13.25] %TBSA;P = .009),机械通气时间更长(6.50 [2.75 - 17.00] vs 3.00 [1.00 - 8.25]天;P = .022),重症监护病房住院时间(LOS)更长(3.00 [3.00 - 28.75] vs 5.50天[2.00 - 11.25];P = .033)。经回归分析,使用肝素是与缩短机械通气时间相关的唯一变量(P = .039)。

结论

雾化吸入肝素联合NAC和沙丁胺醇与机械通气时间显著缩短相关。

相似文献

1
Nebulized Heparin With N-Acetylcysteine and Albuterol Reduces Duration of Mechanical Ventilation in Patients With Inhalation Injury.雾化吸入肝素联合 N-乙酰半胱氨酸和沙丁胺醇可缩短吸入性损伤患者的机械通气时间。
J Pharm Pract. 2019 Apr;32(2):163-166. doi: 10.1177/0897190017747143. Epub 2017 Dec 12.
2
Influence of nebulized unfractionated heparin and N-acetylcysteine in acute lung injury after smoke inhalation injury.雾化普通肝素和N-乙酰半胱氨酸对烟雾吸入性损伤后急性肺损伤的影响。
J Burn Care Res. 2009 Mar-Apr;30(2):249-56. doi: 10.1097/BCR.0b013e318198a268.
3
Outcomes Following the Use of Nebulized Heparin for Inhalation Injury (HIHI Study).雾化肝素用于吸入性损伤后的结果(HIHI研究)。
J Burn Care Res. 2017 Jan/Feb;38(1):45-52. doi: 10.1097/BCR.0000000000000439.
4
Use of Nebulized Heparin, Nebulized N-Acetylcysteine, and Nebulized Epoprostenol in a Patient With Smoke Inhalational Injury and Acute Respiratory Distress Syndrome.雾化肝素、雾化N-乙酰半胱氨酸和雾化依前列醇在一名烟雾吸入性损伤合并急性呼吸窘迫综合征患者中的应用
J Pharm Pract. 2017 Dec;30(6):663-667. doi: 10.1177/0897190016663071. Epub 2016 Aug 16.
5
Heparin/N-acetylcysteine: an adjuvant in the management of burn inhalation injury: a study of different doses.肝素/N-乙酰半胱氨酸:烧伤吸入性损伤治疗中的一种佐剂:不同剂量的研究
J Crit Care. 2014 Feb;29(1):182.e1-4. doi: 10.1016/j.jcrc.2013.06.017. Epub 2013 Aug 8.
6
Nebulized heparin and N-acetylcysteine for smoke inhalational injury: A case report.雾化吸入肝素和N-乙酰半胱氨酸治疗烟雾吸入性损伤:一例报告
Medicine (Baltimore). 2018 May;97(19):e0638. doi: 10.1097/MD.0000000000010638.
7
A Multicenter Evaluation of Outcomes Following the Use of Nebulized Heparin for Inhalation Injury (HIHI2 Study).雾化肝素治疗吸入性损伤(HIHI2 研究)的多中心结局评估。
J Burn Care Res. 2020 Sep 23;41(5):1004-1008. doi: 10.1093/jbcr/iraa101.
8
HEPBURN - investigating the efficacy and safety of nebulized heparin versus placebo in burn patients with inhalation trauma: study protocol for a multi-center randomized controlled trial.《Hepburn 研究:雾化肝素对比安慰剂治疗吸入性损伤烧伤患者的疗效和安全性:一项多中心随机对照试验研究方案》。
Trials. 2014 Mar 25;15:91. doi: 10.1186/1745-6215-15-91.
9
Does a Nebulized Heparin/N-acetylcysteine Protocol Improve Outcomes in Adult Smoke Inhalation?雾化肝素/N-乙酰半胱氨酸方案能否改善成人烟雾吸入的预后?
Plast Reconstr Surg Glob Open. 2014 Jul 9;2(6):e165. doi: 10.1097/GOX.0000000000000121. eCollection 2014 Jun.
10
Nebulized Heparin for Adult Patients With Smoke Inhalation Injury: A Review of the Literature.雾化吸入肝素治疗成年烟雾吸入性损伤患者:文献综述
J Pharm Technol. 2020 Aug;36(4):130-140. doi: 10.1177/8755122520925774. Epub 2020 Jun 1.

引用本文的文献

1
An international RAND/UCLA expert panel to determine the optimal diagnosis and management of burn inhalation injury.一个由 RAND/UCLA 专家组成的国际小组,旨在确定烧伤吸入性损伤的最佳诊断和治疗方法。
Crit Care. 2023 Nov 27;27(1):459. doi: 10.1186/s13054-023-04718-w.
2
Nebulized mesenchymal stem cell derived conditioned medium ameliorates induced pneumonia in a rat model.雾化吸入间充质干细胞来源的条件培养基可改善大鼠模型中的诱导性肺炎。
Front Med (Lausanne). 2023 Jun 2;10:1162615. doi: 10.3389/fmed.2023.1162615. eCollection 2023.
3
Medical and Surgical Care of Critical Burn Patients: A Comprehensive Review of Current Evidence and Practice.
重症烧伤患者的医疗与外科护理:当前证据与实践的全面综述
Cureus. 2022 Nov 15;14(11):e31550. doi: 10.7759/cureus.31550. eCollection 2022 Nov.
4
Patient-centred outcomes are under-reported in the critical care burns literature: a systematic review.患者为中心的结局在重症烧伤文献中报道较少:系统评价。
Trials. 2022 Mar 4;23(1):199. doi: 10.1186/s13063-022-06104-3.
5
Nebulized Heparin for Adult Patients With Smoke Inhalation Injury: A Review of the Literature.雾化吸入肝素治疗成年烟雾吸入性损伤患者:文献综述
J Pharm Technol. 2020 Aug;36(4):130-140. doi: 10.1177/8755122520925774. Epub 2020 Jun 1.
6
"War to the knife" against thromboinflammation to protect endothelial function of COVID-19 patients.“刀兵相见”对抗血栓炎症,保护 COVID-19 患者的内皮功能。
Crit Care. 2020 Jun 19;24(1):365. doi: 10.1186/s13054-020-03060-9.
7
Nebulized heparin for inhalation injury in burn patients: a systematic review and meta-analysis.雾化吸入肝素治疗烧伤患者吸入性损伤:系统评价与荟萃分析
Burns Trauma. 2020 Jun 4;8:tkaa015. doi: 10.1093/burnst/tkaa015. eCollection 2020.
8
Future Trends in Nebulized Therapies for Pulmonary Disease.肺部疾病雾化治疗的未来趋势
J Pers Med. 2020 May 10;10(2):37. doi: 10.3390/jpm10020037.
9
Nebulized Heparin in Burn Patients with Inhalation Trauma-Safety and Feasibility.雾化肝素用于吸入性创伤烧伤患者的安全性与可行性
J Clin Med. 2020 Mar 25;9(4):894. doi: 10.3390/jcm9040894.
10
A Critical Update of the Assessment and Acute Management of Patients with Severe Burns.严重烧伤患者评估与急性处理的重要更新
Adv Wound Care (New Rochelle). 2019 Dec 1;8(12):607-633. doi: 10.1089/wound.2019.0963. Epub 2019 Nov 6.